Systemic corticosteroids for acute exacerbations of chronic obstructive pulmonary disease
Background Acute exacerbations of chronic obstructive pulmonary disease (COPD) are a
major cause of hospital admission and mortality. They contribute to long‐term decline in lung …
major cause of hospital admission and mortality. They contribute to long‐term decline in lung …
Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial
…, KE Wills, L Blizzard, EH Walters, R Wood-Baker - Bmj, 2010 - bmj.com
Objectives To compare standard high flow oxygen treatment with titrated oxygen treatment
for patients with an acute exacerbation of chronic obstructive pulmonary disease in the …
for patients with an acute exacerbation of chronic obstructive pulmonary disease in the …
Influenza vaccine for patients with chronic obstructive pulmonary disease
P Poole, EE Chacko, R Wood‐Baker… - Cochrane Database of …, 2006 - cochranelibrary.com
Background Influenza vaccinations are currently recommended in the care of people with
COPD, but these recommendations are based largely on evidence from observational studies …
COPD, but these recommendations are based largely on evidence from observational studies …
Childhood predictors of lung function trajectories and future COPD risk: a prospective cohort study from the first to the sixth decade of life
…, I Feather, KJ Allen, R Wood-Baker… - The lancet Respiratory …, 2018 - thelancet.com
Background Lifetime lung function is related to quality of life and longevity. Over the lifespan,
individuals follow different lung function trajectories. Identification of these trajectories, their …
individuals follow different lung function trajectories. Identification of these trajectories, their …
Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive …
…, C Ward, S Weston, HK Muller, R WOOD‐BAKER… - …, 2010 - Wiley Online Library
Background and objective: In COPD, the airways are chronically inflamed, and we have now
observed fragmentation of the reticular basement membrane (Rbm). This appears to be a …
observed fragmentation of the reticular basement membrane (Rbm). This appears to be a …
Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease
Background Current guidelines recommend that patients with acute exacerbations of chronic
obstructive pulmonary disease (COPD) should be treated with systemic corticosteroid for …
obstructive pulmonary disease (COPD) should be treated with systemic corticosteroid for …
Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease
…, P Poole, RH Granger, R Wood‐Baker - Cochrane Database …, 2010 - cochranelibrary.com
Background As chronic obstructive pulmonary disease (COPD) progresses, exacerbations
can occur with increasing frequency. One goal of therapy is to prevent these exacerbations, …
can occur with increasing frequency. One goal of therapy is to prevent these exacerbations, …
Lifetime spirometry patterns of obstruction and restriction, and their risk factors and outcomes: a prospective cohort study
…, CV Senaratna, NS Idrose, RR Wood-Baker… - The Lancet …, 2023 - thelancet.com
Background Interest in lifetime lung function trajectories has increased in the context of
emerging evidence that chronic obstructive pulmonary disease (COPD) can arise from multiple …
emerging evidence that chronic obstructive pulmonary disease (COPD) can arise from multiple …
Cardioselective beta‐blockers for reversible airway disease
…, EE Salpeter, R Wood‐Baker… - Cochrane Database …, 1996 - cochranelibrary.com
Background Beta‐blocker therapy has mortality benefit in patients with hypertension, heart
failure and coronary artery disease, as well as during the perioperative period. These drugs …
failure and coronary artery disease, as well as during the perioperative period. These drugs …
Pneumococcal vaccines for preventing pneumonia in chronic obstructive pulmonary disease
…, JNQ Tang, P Poole, R Wood‐Baker - Cochrane Database …, 2017 - cochranelibrary.com
Background People with chronic obstructive pulmonary disease (COPD) are at increased
risk of pneumococcal disease, especially pneumonia, as well as acute exacerbations with …
risk of pneumococcal disease, especially pneumonia, as well as acute exacerbations with …